Fluvastatin Sodium is the sodium salt of a synthetic lipid-lowering agent with potential antineoplastic activity. Fluvastatin competitively inhibits hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses through the suppression of MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells including human vascular endothelial cells. Through the inhibition of mevalonate synthesis, statins, like fluvastatin, have been shown to inhibit the production of dolichol, geranylpyrophosphate (GPP) and farnesylpyrophosphate (FPP) and the isoprenylation of the intracellular G-proteins Ras and Rho, which may result in antiangiogenic, apoptotic, and antimetastatic effects in susceptible tumor cell populations. It is grouped under the following drug class(es): Cholesterol-reducing agents, Lipid-lowering agents and Statins. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Fractal, Fluindostatin, Lipaxan, Locol and Canef. Its PubChem CID is 23679527.
Fluvastatin sodium
| CAS No | 93957-55-2 |
|---|---|
| Molecular Formula | C24H25FNNaO4 |
| Molecular Weight | 433.40 g/mol |
| Synonyms | sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Fluvastatin Sodium is the sodium salt of a synthetic lipid-lowering agent with potential antineoplastic activity. Fluvastatin competitively inhibits hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis.
The listed CAS number is 93957-55-2.
The listed molecular formula is C24H25FNNaO4.
The listed molecular weight is 433.40 g/mol.
sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate.
The source lists Fractal, Fluindostatin, Lipaxan, Locol and Canef.